These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 32221812)

  • 1. Memory T cells: strategies for optimizing tumor immunotherapy.
    Liu Q; Sun Z; Chen L
    Protein Cell; 2020 Aug; 11(8):549-564. PubMed ID: 32221812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-memory cells against cancer: Remembering the enemy.
    Sarkar I; Pati S; Dutta A; Basak U; Sa G
    Cell Immunol; 2019 Apr; 338():27-31. PubMed ID: 30928016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory T cell, exhaustion, and tumor immunity.
    Ando M; Ito M; Srirat T; Kondo T; Yoshimura A
    Immunol Med; 2020 Mar; 43(1):1-9. PubMed ID: 31822213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy.
    Kondo T; Imura Y; Chikuma S; Hibino S; Omata-Mise S; Ando M; Akanuma T; Iizuka M; Sakai R; Morita R; Yoshimura A
    Cancer Sci; 2018 Jul; 109(7):2130-2140. PubMed ID: 29790621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of memory T cell subsets for adoptive immunotherapy.
    Busch DH; Fräßle SP; Sommermeyer D; Buchholz VR; Riddell SR
    Semin Immunol; 2016 Feb; 28(1):28-34. PubMed ID: 26976826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer immunotherapy and immunological memory].
    Murata K; Tsukahara T; Torigoe T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):18-22. PubMed ID: 27181230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
    Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity.
    Pilipow K; Scamardella E; Puccio S; Gautam S; De Paoli F; Mazza EM; De Simone G; Polletti S; Buccilli M; Zanon V; Di Lucia P; Iannacone M; Gattinoni L; Lugli E
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting thiol expression increases the durability of antitumor T-cell functions.
    Kesarwani P; Al-Khami AA; Scurti G; Thyagarajan K; Kaur N; Husain S; Fang Q; Naga OS; Simms P; Beeson G; Voelkel-Johnson C; Garrett-Mayer E; Beeson CC; Nishimura MI; Mehrotra S
    Cancer Res; 2014 Nov; 74(21):6036-6047. PubMed ID: 25164014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory.
    Oliveira G; Ruggiero E; Stanghellini MT; Cieri N; D'Agostino M; Fronza R; Lulay C; Dionisio F; Mastaglio S; Greco R; Peccatori J; Aiuti A; Ambrosi A; Biasco L; Bondanza A; Lambiase A; Traversari C; Vago L; von Kalle C; Schmidt M; Bordignon C; Ciceri F; Bonini C
    Sci Transl Med; 2015 Dec; 7(317):317ra198. PubMed ID: 26659572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell like memory T cells: A new paradigm in cancer immunotherapy.
    Wang F; Cheng F; Zheng F
    Clin Immunol; 2022 Aug; 241():109078. PubMed ID: 35840054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curtailed T-cell activation curbs effector differentiation and generates CD8
    Zanon V; Pilipow K; Scamardella E; De Paoli F; De Simone G; Price DA; Martinez Usatorre A; Romero P; Mavilio D; Roberto A; Lugli E
    Eur J Immunol; 2017 Sep; 47(9):1468-1476. PubMed ID: 28671275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T-cell memory in tumor immunology and immunotherapy.
    Klebanoff CA; Gattinoni L; Restifo NP
    Immunol Rev; 2006 Jun; 211():214-24. PubMed ID: 16824130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapeutic Potential of T Memory Stem Cells.
    Li Y; Wu D; Yang X; Zhou S
    Front Oncol; 2021; 11():723888. PubMed ID: 34604060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
    Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
    J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory CD4
    Vahidi Y; Faghih Z; Talei AR; Doroudchi M; Ghaderi A
    Cell Oncol (Dordr); 2018 Feb; 41(1):1-11. PubMed ID: 28994018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by and maintenance of CD4 effector memory and effector T cell subsets in persistent malaria infection.
    Opata MM; Ibitokou SA; Carpio VH; Marshall KM; Dillon BE; Carl JC; Wilson KD; Arcari CM; Stephens R
    PLoS Pathog; 2018 Apr; 14(4):e1006960. PubMed ID: 29630679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α
    Cheung KW; Wu T; Ho SF; Wong YC; Liu L; Wang H; Chen Z
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection.
    Qian C; Wang Y; Cai H; Laroye C; De Carvalho Bittencourt M; Clement L; Stoltz JF; Decot V; Reppel L; Bensoussan D
    J Immunother; 2016 Jan; 39(1):27-35. PubMed ID: 26641259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.